首页 正文

An updated patent review of p38 MAP kinase inhibitors (2014-2019)

{{output}}
Introduction: During the first half of the last decade the p38 MAP kinase family was a very popular target in academic as well as industrial research programs. Many attempts to achieve marketing authorization for a p38 MAPK inhibitor for the treatment of pro-i... ...